MTOR and lung cancer: Genetic alterations of EGFR, MAP2K1, mTOR, TEAD1, and YAP1 in The Cancer Genome Atlas (TCGA) cohorts of lung cancer occurred at respective frequencies of 15.0%, 1.80%, 6.00%, 1.80%, and 2.50% (Figure 2A).